Ron Arison, MD
Surgery · Fort Lauderdale, FLNPI 1366406563
Payments from drug & device makers
Across 32 payments — averaging $26.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$156
- Organogenesis Inc.$155
- Integra Lifesciences Corporation$70
- Paratek Pharmaceuticals, Inc.$54
- Kerecis Limited$50
- Molnlycke Health Care US, LLC$46
- plus $312 from 13 others
What the payments were for
- Food & beverage$83099%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 3 | $156 |
| Organogenesis Inc. | 7 | $155 |
| Integra Lifesciences Corporation | 3 | $70 |
| Paratek Pharmaceuticals, Inc. | 3 | $54 |
| Kerecis Limited | 1 | $50 |
| Molnlycke Health Care US, LLC | 1 | $46 |
| Davol Inc. | 1 | $46 |
| Smith+Nephew | 2 | $45 |
| TELA Bio, Inc. | 1 | $33 |
| Mallinckrodt Enterprises LLC | 1 | $28 |
| Portola Pharmaceuticals, LLC | 1 | $25 |
| Artivion, Inc. | 1 | $22 |
| Innocoll Pharmaceuticals Limited | 1 | $20 |
| TEI Medical Inc. | 1 | $19 |
| Melinta Therapeutics, LLC | 1 | $18 |
| Acera Surgical, Inc. | 1 | $17 |
| Solventum Corporation | 1 | $14 |
| Tactile Systems Technology Inc | 1 | $13 |
| Bioventus LLC | 1 | $13 |
How this compares
$842 in reported general payments places this provider in the 30th percentile of 1,569 surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gentamicin Sulfate | 64 | $2,876 |
| Mupirocin | 67 | $530 |
| Doxycycline Hyclate | 37 | $515 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 84 | $395 |
| Acetic Acid | 22 | $269 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 16 | $264 |
| Levofloxacin | 27 | $192 |
| Ciprofloxacin Hcl | 21 | $167 |
| ClopidogrelClopidogrel Bisulfate | 12 | $75 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 13 | $70 |
| Tramadol Hcl | 14 | $38 |
Paid to pharmacies, not to this prescriber.
Other surgery in Fort Lauderdale
- Jorge FlorinWinter Garden$2.2M
- Steven FagienBoca Raton$1.6M
- John MullinaxTampa$1.5M
- Amit TaggarTampa$1.4M
- Panagiotis SarantosGainesville$1.3M
- Keith KimCelebration$1.1M
- Christopher DucoinTampa$1.1M
- Andre TeixeiraOcala$1M
- Richard DiciccoTampa$964K
- Salvatore DocimoTampa$950K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.